The abstract is read at the publisher; the summary is JClub's.
AST-BrM astrocytes are selectively reprogrammed at the brain metastasis tumor-microenvironment interface, forming recurrent peritumoral states shared across breast, lung, and melanoma origins.
- Why it matters: Reactive astrocytes are known to support the brain metastasis niche, but a state-resolved, spatially organized map of metastasis-associated astrocyte programs was missing.
- What they did: The study integrated single-cell and spatial transcriptomics across syngeneic breast, lung, and melanoma brain metastasis models to define a tumor-associated astrocyte landscape and two actionable programs.
- The result: Genetic and pharmacologic perturbations support functional relevance, and an AP-1/c-FOS-driven signature is linked to clinical outcome, implying conserved therapeutic targets.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.